KYNB
Kyntra Bio
KYNB
KYNB
30 hedge funds and large institutions have $5.62M invested in Kyntra Bio in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 16
86% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
30
Holding in Top 10
–
Calls
$1.82M
Puts
$306K
Top Buyers
| 1 | +$172K | |
| 2 | +$109K | |
| 3 | +$6.24K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.78K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.39K |
Top Sellers
| 1 | -$437K | |
| 2 | -$411K | |
| 3 | -$210K | |
| 4 |
Millennium Management
New York
|
-$137K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$125K |